CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 164 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,281,931 | -20.1% | 35,629 | -1.1% | 0.05% | -15.3% |
| Q4 2022 | $1,605,411 | +302.4% | 36,020 | +207.8% | 0.06% | +293.3% |
| Q1 2022 | $399,000 | -36.1% | 11,702 | -27.6% | 0.02% | -37.5% |
| Q4 2021 | $624,000 | +13.0% | 16,161 | -48.7% | 0.02% | +33.3% |
| Q4 2020 | $552,000 | – | 31,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,388,967 | $125,425,669 | 9.68% |
| 5AM Venture Management, LLC | 497,270 | $18,403,963 | 4.12% |
| COMMODORE CAPITAL LP | 1,425,000 | $52,739,250 | 3.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 374,910 | $13,875,419 | 3.27% |
| TSP Capital Management Group, LLC | 249,220 | $9,223,635 | 2.89% |
| Eventide Asset Management | 3,327,132 | $123,137,155 | 2.11% |
| Affinity Asset Advisors, LLC | 475,400 | $17,594,554 | 2.03% |
| Novo Holdings A/S | 850,000 | $31,458,500 | 1.83% |
| Bellevue Group AG | 2,971,615 | $109,979,471 | 1.79% |
| Redmile Group, LLC | 718,723 | $26,599,938 | 1.61% |